C4XD.L Conformetrics and its applica6on in drug discovery
|
|
- Jennifer Stephens
- 5 years ago
- Views:
Transcription
1 C4XD.L Conformetrics and its applica6on in drug discovery Dr Thorsten owak; 1 st Anglo-ordic-MedChem Conference 11 th 14 th June
2 CTET Conformetrics, what it is and how its used in drug discovery at C4X IntroducDon Experimentally led conformadonal analysis C4X Discovery Technology in a nutshell ApplicaDon of the technology highlights from projects... ü Keap1/rf2 PPIs ü IL17 PPIs 2
3 CFRMATIAL AALYSIS DRIVE BY EXPERIMET Experimentally determined conforma6onal preferences L-histidine H H 3 FAJMIP 3
4 X-RAY CRYSTALLGRAPHY Mul6ple forms of a single molecule in the CSD can reflect conforma6onal diversity and preferences L-histidine χ1 χ2 H H 3 χ2 χ1 CSD crystal conformations 75 forms (some organic salts; Asp, AMP, camp) (divalent metal ions may skew populations) 4
5 HISTIDIE SLUTI ESEMBLE FRM MR DATA Free solu6on 4D-structure L-histidine H H 3 χ2 χ ±0.05 χ1 libration 14± ± ± ±6 0.27±0.05 χ2 libration 18±8 90±6 0.22± ±6 0.49±0.08 Ensemble-4D 5
6 HISTIDIE SLUTI ESEMBLE FRM MR DATA Free solu6on 4D-structure 0.25 χ1 χ ±0.05 libration 14±7 libration 18± ± ±6 0.27± ±6 0.22± χ ± ±6 0.49±0.08 Ensemble-4D 6
7 SLID STATE VS SLUTI CFRMATIS χ1 χ2 Free solution 4D-structure ± ± ±6 0.27± ±6 0.22±0.05 H H 3 χ2 χ1 libration 14± ±0.09 libration 18±8 114±6 0.49±0.08 CSD crystal conformations 75 forms 7
8 PRPRIETARY, PATETED-PRTECTED METHDLGY MR data Proprietary sozware suite 4D-structure Quan6fica6on of free ligand conforma6onal preferences by MR and their rela6onship to the bioac6ve conforma6on Blundell CD, Packer MJ and Almond A, Bioorganic & Medicinal Chemistry, 21 (17), (2013) 8
9 APPLICABLE T ALL DRUG AD TARGET CLASSES TARGET AGSTIC 9
10 SLUTI 4D-STRUCTURES PREDICT TARGET-BUD (BIACTIVE) CFRMATIS BrefeldinA Simpanorm Devomycin CydecDn Lisinopril Gleevec Hyaluronic acid 10
11 C4XD.L The power of combining Conformetrics and Docking strategies for SBDD Keap1/rf-2 PPIs
12 EXPERIMETALLY CHARACTERISED BUD VERSUS UBUD FRMS Rigidity How much and where? Is excessive rigidity the reason for poor affinity? Are non-optimal interactions the reasons for weak affinity (~1µM [LE 0.25])? H SRS- 5 2 idealised conformers Hu, L.; et al. Bioorg. Med. Chem. Le^. (2013), 23, Bound vs Solution 12
13 DCKIG STUDIES (GLIDE) FLEXIBLE LIGAD APPRACH Flexible ligand docking with post docking minimiza6on input crystal structure conforma6on (4L7B) (a) Rank: 1, 2, 7 (b) Rank: 3, 5, 10 Jan-Christoph Westermann 13
14 DCKIG STUDIES (GLIDE) RIGID LIGAD APPRACH Rigid body docking of C4X conforma6onal ensemble (250 conformers) with post-docking minimiza6on Minor Conformer 7% Major Conformer 90% (a) 4L7B (b) Rank: 1 20 (Approx. 3% minor E-Amide Conformer) Jan-Christoph Westermann 14
15 TARGETED, CFRMATIALLY CTRLLED LIGAD GRWTH Prove of hypothesis that ligand extension leads to potency increase Target ligand growth using conformadonal database informadon to design linkers C4XD internal knowledge CSD knowledge base PDB knowledge base 15
16 C4XD.L The power of conforma6onal restric6on IL-17 - PPIs
17 IL-17 WHAT IS KW? Conforma6onal diversity as an opportunity SRS-5 Keap1/rf-2 Pfizer IL17 inhibitor H H H H F 2 idealised conformers extremely rigid Liu, S., et al. Scientific Reports, (2016), 6, idealised conformers extremely flexible 17
18 IL-17 KW LIGADS AD THE BIDIG MDES PDB 5HI3; DI: /srep
19 IL-17 CFRMATIAL DIVERSITY AS A PPRTUITY I DRUG DISCVERY Ra6onal reduc6on of conforma6onal diversity as a design opportunity 480 idealised conformers 19
20 IMPACT F CFRMATIAL DESIG IL-17 PTECY Ensemble References Pfizer open chain LE HI Project Phase H2L 20
21 SUMMARY Conforma6onal design is an integral strategy in medicinal chemistry Experimentally determined conformadonal data are rich sources for design strategies complemendng tradidonal potency and property focused approaches. Experimentally determined conformadonal data expand the udlity of structural biology informadon. Experimentally determined conformadonal data offers addidonal opportunides for computadonal chemistry. 21
22 ACKWLEDGEMETS C4X Colleagues Collaborators/Providers of tools Wojtek Augustyniak Jan-Christoph Westermann Sadia Mohammed Jon Bryne MarDn Watson Charles Blundell ick Ray Barrie MarDn Emma Blaney Proteros Biostructures GmbH Schrodinger Inc. The Cambridge Crystallographic Datacentre 22
23 C4XD.L Thank you! 23
Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation
Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Charles Blundell charles.blundell@c4xdiscovery.com www.c4xdiscovery.com Rigid: single
More informationToward an Understanding of GPCR-ligand Interactions. Alexander Heifetz
Toward an Understanding of GPCR-ligand Interactions Alexander Heifetz UK QSAR and ChemoInformatics Group Conference, Cambridge, UK October 6 th, 2015 Agenda Fragment Molecular Orbitals (FMO) for GPCR exploration
More informationCSD. Unlock value from crystal structure information in the CSD
CSD CSD-System Unlock value from crystal structure information in the CSD The Cambridge Structural Database (CSD) is the world s most comprehensive and up-todate knowledge base of crystal structure data,
More informationAnalyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre
Analyzing Molecular Conformations Using the Cambridge Structural Database Jason Cole Cambridge Crystallographic Data Centre 1 The Cambridge Structural Database (CSD) 905,284* USOPEZ a natural product intermediate,
More informationMD Simulation in Pose Refinement and Scoring Using AMBER Workflows
MD Simulation in Pose Refinement and Scoring Using AMBER Workflows Yuan Hu (On behalf of Merck D3R Team) D3R Grand Challenge 2 Webinar Department of Chemistry, Modeling & Informatics Merck Research Laboratories,
More informationDr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
More informationData Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
More informationFragment Hotspot Maps: A CSD-derived Method for Hotspot identification
Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Chris Radoux www.ccdc.cam.ac.uk radoux@ccdc.cam.ac.uk 1 Introduction Hotspots Strongly attractive to organic molecules Organic molecules
More informationHigh Throughput In-Silico Screening Against Flexible Protein Receptors
John von Neumann Institute for Computing High Throughput In-Silico Screening Against Flexible Protein Receptors H. Sánchez, B. Fischer, H. Merlitz, W. Wenzel published in From Computational Biophysics
More informationFRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )
FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC ) SARomics Biostructures AB & Red Glead Discovery AB Medicon Village, Lund, Sweden Fragment-based lead discovery The basic idea:
More informationHit Finding and Optimization Using BLAZE & FORGE
Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology
More informationMM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors
MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors Thomas Steinbrecher Senior Application Scientist Typical Docking Workflow Databases
More informationStructure-based maximal affinity model predicts small-molecule druggability
Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results
More informationGenerating Small Molecule Conformations from Structural Data
Generating Small Molecule Conformations from Structural Data Jason Cole cole@ccdc.cam.ac.uk Cambridge Crystallographic Data Centre 1 The Cambridge Crystallographic Data Centre About us A not-for-profit,
More informationDifferent conformations of the drugs within the virtual library of FDA approved drugs will be generated.
Chapter 3 Molecular Modeling 3.1. Introduction In this study pharmacophore models will be created to screen a virtual library of FDA approved drugs for compounds that may inhibit MA-A and MA-B. The virtual
More informationIntroduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
More informationThe PhilOEsophy. There are only two fundamental molecular descriptors
The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationStructural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
More informationFlexibility and Constraints in GOLD
Flexibility and Constraints in GOLD Version 2.1 August 2018 GOLD v5.6.3 Table of Contents Purpose of Docking... 3 GOLD s Evolutionary Algorithm... 4 GOLD and Hermes... 4 Handling Flexibility and Constraints
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationMachine-learning scoring functions for docking
Machine-learning scoring functions for docking Dr Pedro J Ballester MRC Methodology Research Fellow EMBL-EBI, Cambridge, United Kingdom EBI is an Outstation of the European Molecular Biology Laboratory.
More informationThe Schrödinger KNIME extensions
The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich Topics What are the Schrödinger extensions? Workflow application
More informationOverview & Applications. T. Lezon Hands-on Workshop in Computational Biophysics Pittsburgh Supercomputing Center 04 June, 2015
Overview & Applications T. Lezon Hands-on Workshop in Computational Biophysics Pittsburgh Supercomputing Center 4 June, 215 Simulations still take time Bakan et al. Bioinformatics 211. Coarse-grained Elastic
More informationBioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw
More informationProtein-Ligand Docking Evaluations
Introduction Protein-Ligand Docking Evaluations Protein-ligand docking: Given a protein and a ligand, determine the pose(s) and conformation(s) minimizing the total energy of the protein-ligand complex
More informationApplications of Fragment Based Approaches
Applications of Fragment Based Approaches Ben Davis Vernalis R&D, Cambridge UK b.davis@vernalis.com 1 Applications of Fragment Based Approaches creening fragment libraries Techniques Vernalis eeds approach
More informationMechanistic insight into inhibition of two-component system signaling
Supporting Information Mechanistic insight into inhibition of two-component system signaling Samson Francis, a Kaelyn E. Wilke, a Douglas E. Brown a and Erin E. Carlson a,b* a Department of Chemistry,
More informationBIOINF 4371 Drug Design 1 Oliver Kohlbacher & Jens Krüger
BIOINF 4371 Drug Design 1 Oliver Kohlbacher & Jens Krüger Winter 2013/2014 11. Docking Part IV: Receptor Flexibility Overview Receptor flexibility Types of flexibility Implica5ons for docking Examples
More informationFondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction
Fondamenti di Chimica Farmaceutica Computer Chemistry in Drug Research: Introduction Introduction Introduction Introduction Computer Chemistry in Drug Design Drug Discovery: Target identification Lead
More informationProtein Structure Prediction and Protein-Ligand Docking
Protein Structure Prediction and Protein-Ligand Docking Björn Wallner bjornw@ifm.liu.se Jan. 24, 2014 Todays topics Protein Folding Intro Protein structure prediction How can we predict the structure of
More informationICM-Chemist-Pro How-To Guide. Version 3.6-1h Last Updated 12/29/2009
ICM-Chemist-Pro How-To Guide Version 3.6-1h Last Updated 12/29/2009 ICM-Chemist-Pro ICM 3D LIGAND EDITOR: SETUP 1. Read in a ligand molecule or PDB file. How to setup the ligand in the ICM 3D Ligand Editor.
More informationCSD. CSD-Enterprise. Access the CSD and ALL CCDC application software
CSD CSD-Enterprise Access the CSD and ALL CCDC application software CSD-Enterprise brings it all: access to the Cambridge Structural Database (CSD), the world s comprehensive and up-to-date database of
More informationExamples of Protein Modeling. Protein Modeling. Primary Structure. Protein Structure Description. Protein Sequence Sources. Importing Sequences to MOE
Examples of Protein Modeling Protein Modeling Visualization Examination of an experimental structure to gain insight about a research question Dynamics To examine the dynamics of protein structures To
More informationApplying Bioisosteric Transformations to Predict Novel, High Quality Compounds
Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds Dr James Chisholm,* Dr John Barnard, Dr Julian Hayward, Dr Matthew Segall*, Mr Edmund Champness*, Dr Chris Leeding,* Mr Hector
More informationDOCKING TUTORIAL. A. The docking Workflow
2 nd Strasbourg Summer School on Chemoinformatics VVF Obernai, France, 20-24 June 2010 E. Kellenberger DOCKING TUTORIAL A. The docking Workflow 1. Ligand preparation It consists in the standardization
More informationComputational chemical biology to address non-traditional drug targets. John Karanicolas
Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints
More informationVirtual Screening: How Are We Doing?
Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global
More informationUser Guide for LeDock
User Guide for LeDock Hongtao Zhao, PhD Email: htzhao@lephar.com Website: www.lephar.com Copyright 2017 Hongtao Zhao. All rights reserved. Introduction LeDock is flexible small-molecule docking software,
More informationKd = koff/kon = [R][L]/[RL]
Taller de docking y cribado virtual: Uso de herramientas computacionales en el diseño de fármacos Docking program GLIDE El programa de docking GLIDE Sonsoles Martín-Santamaría Shrödinger is a scientific
More informationENERGY MINIMIZATION AND CONFORMATION SEARCH ANALYSIS OF TYPE-2 ANTI-DIABETES DRUGS
Int. J. Chem. Sci.: 6(2), 2008, 982-992 EERGY MIIMIZATI AD CFRMATI SEARC AALYSIS F TYPE-2 ATI-DIABETES DRUGS R. PRASAA LAKSMI a, C. ARASIMA KUMAR a, B. VASATA LAKSMI, K. AGA SUDA, K. MAJA, V. JAYA LAKSMI
More informationPose and affinity prediction by ICM in D3R GC3. Max Totrov Molsoft
Pose and affinity prediction by ICM in D3R GC3 Max Totrov Molsoft Pose prediction method: ICM-dock ICM-dock: - pre-sampling of ligand conformers - multiple trajectory Monte-Carlo with gradient minimization
More informationLife Science Webinar Series
Life Science Webinar Series Elegant protein- protein docking in Discovery Studio Francisco Hernandez-Guzman, Ph.D. November 20, 2007 Sr. Solutions Scientist fhernandez@accelrys.com Agenda In silico protein-protein
More informationIdentifying Interaction Hot Spots with SuperStar
Identifying Interaction Hot Spots with SuperStar Version 1.0 November 2017 Table of Contents Identifying Interaction Hot Spots with SuperStar... 2 Case Study... 3 Introduction... 3 Generate SuperStar Maps
More informationDispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,
More informationЖ У Р Н А Л С Т Р У К Т У Р Н О Й Х И М И И Том 50, 5 Сентябрь октябрь С
Ж У Р Н А Л С Т Р У К Т У Р Н О Й Х И М И И 2009. Том 50, 5 Сентябрь октябрь С. 873 877 UDK 539.27 STRUCTURAL STUDIES OF L-SERYL-L-HISTIDINE DIPEPTIDE BY MEANS OF MOLECULAR MODELING, DFT AND 1 H NMR SPECTROSCOPY
More informationSynthetic organic compounds
Synthetic organic compounds for research and drug discovery Compounds for TS Fragment libraries Target-focused libraries Chemical building blocks Custom synthesis Drug discovery services Contract research
More informationThe Conformation Search Problem
Jon Sutter Senior Manager Life Sciences R&D jms@accelrys.com Jiabo Li Senior Scientist Life Sciences R&D jli@accelrys.com CAESAR: Conformer Algorithm based on Energy Screening and Recursive Buildup The
More informationNovel Quinoline and Naphthalene derivatives as potent Antimycobacterial agents
ovel Quinoline and aphthalene derivatives as potent Antimycobacterial agents Ram Shankar Upadhayaya a, Jaya Kishore Vandavasi a, Ramakant A. Kardile a, Santosh V. Lahore a, Shailesh S. Dixit a, Hemantkumar
More informationBuilding innovative drug discovery alliances
Building innovative drug discovery alliances Hit optimisation o using fragments Mark kwhittaker Evotec AG, Fragments 2015, March 2015 Agenda Fragment optimisation in an ideal world Fragment optimisation
More informationRanking of HIV-protease inhibitors using AutoDock
Ranking of HIV-protease inhibitors using AutoDock 1. Task Calculate possible binding modes and estimate the binding free energies for 1 3 inhibitors of HIV-protease. You will learn: Some of the theory
More informationLigand-receptor interactions
University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationBioSolveIT. A Combinatorial Docking Approach for Dealing with Protonation and Tautomer Ambiguities
BioSolveIT Biology Problems Solved using Information Technology A Combinatorial Docking Approach for Dealing with Protonation and Tautomer Ambiguities Ingo Dramburg BioSolve IT Gmb An der Ziegelei 75 53757
More informationSupporting Information
Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model Supporting Information Peter Kolb, Danzhi Huang, Fabian Dey and Amedeo Caflisch
More informationSupporting Online Material for
www.sciencemag.org/cgi/content/full/317/5846/1881/dc1 Supporting Online Material for Fluorine in Pharmaceuticals: Looking Beyond Intuition Klaus Müller,* Christoph Faeh, François Diederich* *To whom correspondence
More informationChemical properties that affect binding of enzyme-inhibiting drugs to enzymes
Chemical properties that affect binding of enzyme-inhibiting drugs to enzymes Introduction The production of new drugs requires time for development and testing, and can result in large prohibitive costs
More informationUsing Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017
Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface
More informationBuild_model v User Guide
Build_model v.2.0.1 User Guide MolTech Build_model User Guide 2008-2011 Molecular Technologies Ltd. www.moltech.ru Please send your comments and suggestions to contact@moltech.ru. Table of Contents Input
More informationStatistical concepts in QSAR.
Statistical concepts in QSAR. Computational chemistry represents molecular structures as a numerical models and simulates their behavior with the equations of quantum and classical physics. Available programs
More informationVirtual screening in drug discovery
Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery
More informationDocking with Water in the Binding Site using GOLD
Docking with Water in the Binding Site using GOLD Version 2.0 November 2017 GOLD v5.6 Table of Contents Docking with Water in the Binding Site... 2 Case Study... 3 Introduction... 3 Provided Input Files...
More informationLigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer
LigandScout Automated Structure-Based Pharmacophore Model Generation Gerhard Wolber* and Thierry Langer * E-Mail: wolber@inteligand.com Pharmacophores from LigandScout Pharmacophores & the Protein Data
More informationNMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease
University of Wollongong Research Online Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 2009 NMR study of complexes between low molecular mass inhibitors and the West Nile
More informationBridging the Dimensions:
Bridging the Dimensions: Seamless Integration of 3D Structure-based Design and 2D Structure-activity Relationships to Guide Medicinal Chemistry ACS Spring National Meeting. COMP, March 13 th 2016 Marcus
More informationSchrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist
Schrodinger ebootcamp #3, Summer 2016 EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Numerous applications Generating conformations MM Agenda http://www.schrodinger.com/macromodel
More informationSpacer conformation in biologically active molecules*
Pure Appl. Chem., Vol. 76, No. 5, pp. 959 964, 2004. 2004 IUPAC Spacer conformation in biologically active molecules* J. Karolak-Wojciechowska and A. Fruziński Institute of General and Ecological Chemistry,
More informationThe Cambridge Structural Database (CSD) a Vital Resource for Structural Chemistry and Biology Stephen Maginn, CCDC, Cambridge, UK
The Cambridge Structural Database (CSD) a Vital Resource for Structural Chemistry and Biology Stephen Maginn, CCDC, Cambridge, UK 1 The Cambridge Crystallographic Data Centre The advancement and promotion
More informationCHAPTER-5 MOLECULAR DOCKING STUDIES
CHAPTER-5 MOLECULAR DOCKING STUDIES 156 CHAPTER -5 MOLECULAR DOCKING STUDIES 5. Molecular docking studies This chapter discusses about the molecular docking studies of the synthesized compounds with different
More informationTowards Physics-based Models for ADME/Tox. Tyler Day
Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages
More informationGC and CELPP: Workflows and Insights
GC and CELPP: Workflows and Insights Xianjin Xu, Zhiwei Ma, Rui Duan, Xiaoqin Zou Dalton Cardiovascular Research Center, Department of Physics and Astronomy, Department of Biochemistry, & Informatics Institute
More informationStructure of proteins modeling and drug design
Structure of proteins modeling and drug design Marcus Elstner and Tomáš Kubař July 20, 2016 Structure of proteins Structure of proteins Structure of proteins Basic principles of protein structure very
More informationJoana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)
Joana Pereira Lamzin Group EMBL Hamburg, Germany Small molecules How to identify and build them (with ARP/wARP) The task at hand To find ligand density and build it! Fitting a ligand We have: electron
More informationUsing AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
More informationPeptide-derived Inhibitors of Protein-Protein Interactions
Peptide-derived Inhibitors of Protein-Protein Interactions Sven Hennig Department of Chemistry and Pharmaceutical Sciences Vrije Universiteit Amsterdam 1 Biomolecular recognitions Classification via interaction
More informationFragment based drug discovery in teams of medicinal and computational chemists. Carsten Detering
Fragment based drug discovery in teams of medicinal and computational chemists Carsten Detering BioSolveIT Quick Facts Founded in 2001 by the developers of FlexX ~20 people Core expertise: docking, screening,
More informationPose Prediction with GOLD
Pose Prediction with GOLD Version 3.0 November 2018 GOLD v5.7.0 Table of Contents The Purpose of Docking... 2 GOLD s Evolutionary Algorithm... 3 A Checklist for Docking... 3 GOLD and Hermes... 3 Redocking
More informationImplementation of novel tools to facilitate fragment-based drug discovery by NMR:
Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry
More informationCHEM 4170 Problem Set #1
CHEM 4170 Problem Set #1 0. Work problems 1-7 at the end of Chapter ne and problems 1, 3, 4, 5, 8, 10, 12, 17, 18, 19, 22, 24, and 25 at the end of Chapter Two and problem 1 at the end of Chapter Three
More informationDirect Method. Very few protein diffraction data meet the 2nd condition
Direct Method Two conditions: -atoms in the structure are equal-weighted -resolution of data are higher than the distance between the atoms in the structure Very few protein diffraction data meet the 2nd
More informationest Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today
est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today Sign up for FREE GPU Test Drive on remotely hosted clusters www.nvidia.com/gputestd rive Shape Searching
More informationSynthetic organic compounds
Synthetic organic compounds for research and drug discovery chemicals Compounds for TS Fragment libraries Target-focused libraries Chemical building blocks Custom synthesis Drug discovery services Contract
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design
Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Computer Aided Drug Design - Introduction Development
More informationSupporting Information
S-1 Supporting Information Flaviviral protease inhibitors identied by fragment-based library docking into a structure generated by molecular dynamics Dariusz Ekonomiuk a, Xun-Cheng Su b, Kiyoshi Ozawa
More informationSensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets
Supporting information Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets Wan-Na Chen, Christoph Nitsche, Kala Bharath Pilla, Bim Graham, Thomas
More informationThe Schrödinger KNIME extensions
The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich KNIME UGM, Berlin, February 2015 The Schrödinger Extensions
More informationIntegrated Cheminformatics to Guide Drug Discovery
Integrated Cheminformatics to Guide Drug Discovery Matthew Segall, Ed Champness, Peter Hunt, Tamsin Mansley CINF Drug Discovery Cheminformatics Approaches August 23 rd 2017 Optibrium, StarDrop, Auto-Modeller,
More informationDrug targets, Protein Structures and Crystallography
Drug targets, Protein Structures and Crystallography NS5B viral RNA polymerase (RNA dep) Hepa88s C drug Sofosbuvir (Sovaldi) FDA 2013 Epclusa - combina8on with Velpatasvir approved in in 2016) Prodrug
More informationScoring functions for of protein-ligand docking: New routes towards old goals
3nd Strasbourg Summer School on Chemoinformatics Strasbourg, June 25-29, 2012 Scoring functions for of protein-ligand docking: New routes towards old goals Christoph Sotriffer Institute of Pharmacy and
More informationCreating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner
Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features
More informationStructure based drug design and LIE models for GPCRs
Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser
More informationStructural Perspectives on Drug Resistance
Structural Perspectives on Drug Resistance Irene Weber Departments of Biology and Chemistry Molecular Basis of Disease Program Georgia State University Atlanta, GA, USA What have we learned from 20 years
More informationBioSolveIT. A Combinatorial Approach for Handling of Protonation and Tautomer Ambiguities in Docking Experiments
BioSolveIT Biology Problems Solved using Information Technology A Combinatorial Approach for andling of Protonation and Tautomer Ambiguities in Docking Experiments Ingo Dramburg BioSolve IT Gmb An der
More informationPing-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.
Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical
More informationDevelopment of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso
More informationThe Schrödinger KNIME extensions
The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich KNIME UGM, Zurich, February 2014 The Schrödinger extensions
More informationDatabase Speaks. Ling-Kang Liu ( 劉陵崗 ) Institute of Chemistry, Academia Sinica Nangang, Taipei 115, Taiwan
Database Speaks Ling-Kang Liu ( 劉陵崗 ) Institute of Chemistry, Academia Sinica Nangang, Taipei 115, Taiwan Email: liuu@chem.sinica.edu.tw 1 OUTLINES -- Personal experiences Publication types Secondary publication
More informationGyörgy M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
More informationSupplementary Material
upplementary Material Molecular docking and ligand specificity in fragmentbased inhibitor discovery Chen & hoichet 26 27 (a) 2 1 2 3 4 5 6 7 8 9 10 11 12 15 16 13 14 17 18 19 (b) (c) igure 1 Inhibitors
More informationing equilibrium i Dynamics? simulations on AchE and Implications for Edwin Kamau Protein Science (2008). 17: /29/08
Induced-fit d or Pre-existin ing equilibrium i Dynamics? Lessons from Protein Crystallography yand MD simulations on AchE and Implications for Structure-based Drug De esign Xu Y. et al. Protein Science
More information